| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.21 | 0.0001 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.18 | 0.0003 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0003 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.42 | 0.0003 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0004 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0005 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0005 |